Parnell Living Science Introduces BRD Solution RESPIRmycin
Parnell Living Science announces the launch of RESPIRmycin (tulathromycin injection). RESPIRmycin is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a trusted antibiotic to treat and control bovine respiratory disease (BRD) in cattle.
The prescription antibiotic, recently approved for Parnell by the FDA, is the latest addition to the injectable portfolio of bovine solutions offered by Parnell. RESPIRmycin is manufactured in Parnell’s FDA approved facility and meets all high quality and safety standards.
“Parnell is excited to offer RESPIRmycin to veterinarians and producers as a solution to respiratory disease in cattle,” said Pablo Lamberto, DVM, President U.S. Operations at Parnell Living Science. “This addition to Parnell’s existing products and technologies offer customers the same quality they have experienced with our recognized cattle reproductive solution portfolio including GONAbreed, estroPLAN and mySYNCH.”
Parnell Living Science introduces RESPIRmycin (tulathromycin injection) – a trusted antibiotic for bovine respiratory disease, foot rot and pinkeye, as well as swine respiratory disease. Click here to download a high-resolution image. “Launching RESPIRmycin demonstrates the commitment of Parnell to help veterinarians and producers continually improve livestock health by adhering to the principles of responsible antimicrobial use: Disease prevention, accurate diagnosis and effective treatment,” said Dr. Lamberto.
RESPIRmycin is indicated for use in beef cattle (including suckling calves), non-lactating dairy cattle (including dairy calves), veal calves, and swine. Not for use in female dairy cattle 20 months of age or older.
Beef and Non-Lactating Dairy Cattle
BRD – RESPIRmycin Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
IBK – RESPIRmycin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.
Foot Rot – RESPIRmycin Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Suckling Calves, Dairy Calves, and Veal Calves
BRD – RESPIRmycin Injectable Solution is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
RESPIRmycin Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis and Mycoplasma hyopneumoniae; and for the control of SRD associated with A. pleuropneumoniae, P. multocida and M. hyopneumoniae in groups of pigs where SRD has been diagnosed.
RESPIRmycin is currently available in 50 mL and 100 mL bottles. To learn more, contact your veterinarian or your regional Parnell representative.
Important Safety Information
• Cattle: inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.
• Swine: inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg/kg (0.25 mL/22 lb) BW. Do not inject more than 2.5 mL per injection site.
• Cattle: Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
• Swine: Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.
About Parnell Living Science
Parnell is a fully integrated, veterinary pharmaceutical company focused on developing, manufacturing, and commercializing innovative animal health solutions. We currently manufacture and market six products for companion animals and production animals in 10 countries and augment our production animal pharmaceutical products with proprietary software platform mySYNCH.
To learn more about Parnell’s solutions for cattle, visit www.parnell.com/products/reproduction-products.